Heartworm Preventative And Intestinal Parasite Treatment label

Heartworm Preventative And Intestinal Parasite Treatment

Heartworm Preventative And Intestinal Parasite Treatment Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

For use in dogs only. Keep this and all drugs out of reach of children. In safety studies, testicular hypoplasia was observed in some dogs receiving 3 and 5 times the maximum recommended dose monthly for 6 months (see Animal Safety).

In case of ingestion by humans, clients should be advised to contact a physician immediately. Physicians may contact a Poison Control Center for advice concerning cases of ingestion by humans.

For a copy of the Material Safety Data Sheet (MSDS), or to report adverse reactions, call 1-866-337-5009.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

For use in dogs to prevent canine heartworm disease by eliminating the tissue stage of heartworm larvae (Dirofilaria immitis) for a month (30 days) after infection and for the treatment and control of roundworms (Toxocara canis, Toxascaris leonina), hookworms (Ancylostoma caninum, Uncinaria stenocephala, Ancylostoma braziliense), and tapeworms (Dipylidium caninum, Taenia pisiformis).

History

There is currently no drug history available for this drug.

Other Information

Heartworm Preventative & Intestinal Parasite Treatment Chewable Tablets is a combination of three anthelmintics (ivermectin/pyrantel pamoate/praziquantel). The tablets are available in four sizes in color-coded packages for oral administration to dogs according to their weight (see Dosage).

Heartworm Preventative And Intestinal Parasite Treatment Manufacturers

  • Heartworm Preventative And Intestinal Parasite Treatment | Virbac Ah, Inc.
    No Recall

    Heartworm Preventative And Intestinal Parasite Treatment | Virbac Ah, Inc.

    Heartworm Preventative And Intestinal Parasite Treatment | Virbac Ah, Inc.

    Heartworm Preventative & Intestinal Parasite Treatment (ivermectin/pyrantel pamoate/praziquantel) Chewable Tablets should be administerd orally at monthly intervals at the recommended minimum dose level of 6 mcg of ivermectin per kilogram (2.72 mcg/lb), 5 mg of pyrantel (as pamoate salt) per kg (2.27 mg/lb) and 5 mg of praziquantel per kg (2.27 mg/lb) of body weight, as follows:

    Dog Weight Lbs. Chewable Tablet Per Month Tablet Size Ivermectin Content Pyrantel Pamoate Content Praziquantel Content 6.0 to 12 1 Toy 34 mcg 28.5 mg 28.5 mg 12.1 to 25 1 Small 68 mcg 57 mg 57 mg 25.1 to 50 1 Medium 136 mcg 114 mg 114 mg 50.1 to 100 1 Large 272 mcg 228 mg 228 mg

    Heartworm Preventative & Intestinal Parasite Treatment Chewable Tablets are recommended for 8 weeks of age and older. For dogs over 100 lbs, use the appropriate of these Chewable Tablets.

    Remove only one tablet at a time from the foil-backed blister card. Return the remaining tablets to their box to protect the product from light. Heartworm Preventative & Intestinal Parasite Treatment Chewable Tablets can be offered to the dog by hand or be added intact to a small amount of dog food. Care should be taken that the dog consumes the complete dose, and the dog should be observed for a few minutes after administration to ensure that part of the dose is not lost or rejected. If it is suspected that any of the dose has been lost, redosing is recommended.

    Heartworm Preventative & Intestinal Parasite Treatment Chewable Tablets should be given at monthly intervals during the period of the year when mosquitoes (vectors), potentially carrying infective heartworm larvae, are active. The initial dose must be given within a month (30 days) after the dog's first exposure to mosquitoes. The final dose must be given within a month (30 days) after the dog's last exposure to mosquitoes.

    When replacing another heartworm preventive product in a heartworm disease prevention program, the first dose of Heartworm Preventative & Intestinal Parasite Treatment Chewable Tablets must be given within a month (30 days) of the last dose of the former medication. A heartworm test should be performed prior to switching heartworm preventive products.

    If the interval between doses exceeds a month (30 days), the efficacy of ivermectin can be reduced. Therefore, for optimal performance, the tablet must be given once a month on or about the same day of the month. If treatment is delayed, whether by a few days or many, immediate treatment with Heartworm Preventative & Intestinal Parasite Treatment Chewable Tablets and resumption of the recommended dosing regimen will minimize the opportunity for the development of adult heartworms.